efforts.
of eliminating HAIs (CDC, 2018a; processes and practices related to
SHELLEY JOHNSON, MHA, BSN, RN, CENP, CNL, is Director, Critical Care Services,
NorthBay Healthcare, Fairfield, CA.
2016 Estimated
Additional Cost of
HAI 2015 2016 Care Related to HAIs
CLABSI number 8 9 $144,000
CLABSI rate (number of CLABSI infections/1,000 line days) 1.15 1.15
CLABSI benchmark (NHSN mean) 0.9 0.9
CAUTI number 7 15 $30,000
CAUTI rate (number of CAUTI infections/1,000 urinary catheter days 0.89 1.35
CAUTI benchmark (NHSN mean) 1.25 1.3
C. diff number 66 61 $1,200,000
C. diff rate/10,000 patient days 15.9 12.77
C. diff benchmark (NHSN per 10,000 patient days) 7.4 7.4
Total number of all three HAIs 81 85
Total estimated cost of all three HAIs $1,374,000
CAUTI = catheter-associated urinary tract infection, CLABSI = central line associated bloostream infection, C. diff =
Clostridium difficile, HAI = hospital-acquired infection, NHSN = National Healthcare Safety Network
The primary ways to prevent hos- half million infections, 24% were preventable (IHI, 2012; Sacks et al.,
pital acquired C. diff infections are classified as hospital-acquired 2014).
by thorough caregiver handwash- while 66% were classified as Sacks and colleagues (2014)
ing between patients, limiting healthcare-associated. In 2007, it compared the CLABSI infection
antibiotic use, isolating patients was estimated that C. diff caused rate 1 year pre and 6 months post-
with known C. diff infection, effec- 14,000 deaths and it is anticipated intervention with the IHI CLABSI
tive cleaning of patient rooms that rates of C. diff will continue to prevention bundle in a surgical
using a spore killing cleaner, and rise. This increase may be in part intensive care unit. A same-size
preventing cross-contamination by because of more sensitive testing, medical intensive care unit was the
appropriately cleaning equipment but also because the infection is control unit. Study results showed
between patients and wearing per- highly transmittable (Lessa et al., a 68% decrease in the CLABSI rate
sonal protective equipment (PPE) 2015). on the intervention unit, 12
(CDC, 2012; Dubberke et al., 2014). Catheter-associated blood CLABSIs were prevented, and
C. diff contributes to increased stream infections. Central lines are annual savings in unnecessary
morbidity and mortality and catheters that end in a great vessel patient care costs of $198,600. The
accounts for increased costs of such as the aorta, vena cava, sub- CLABSI prevention bundle in-
care. C. diff infection costs for first- clavian, or femoral veins and are cludes hand hygiene, barrier pre-
time and recurrent infections aver- used for blood withdrawal, hemo- cautions on insertion, chlorhexi-
age between $13,168 and $28,218 dynamic monitoring, or infusions dine skin preparation, site selection
(Shah et al., 2016). Because the C. (CDC, 2018b). Nearly 50% of all such as avoiding the femoral area,
diff spore can live for months on patients in intensive care have a and daily review of line necessity
surfaces, it is easily spread from central line, equating to 82,000 (IHI, 2012).
person to person via hands that central lines used annually in U.S. Valencia and co-authors (2016)
have touched contaminated sur- hospitals. There are 28,000 deaths conducted a worldwide survey in
faces (CDC, 2018a). related to central-line bloodstream intensive care units to assess prac-
C. diff is the most common infections each year. CLABSIs cost tices related to the CLABSI preven-
hospital-acquired pathogen and between $3,700 and $29,000 in tion bundle. They categorized
the leading cause of death associ- additional health care per patient respondents by country and sorted
ated with gastroenteritis (Shah et and can add up to 7 additional the nations into low income, mid-
al., 2016). In 2011, there were over days to a hospital stay. These dle income, and high income. No
half million C. diff infections in infections are expensive, add to low-income countries, 14 middle-
the United States alone. Of those morbidity and mortality, and are income countries, and 27 top-
Event identification Identification of internal and external events Infection prevention notifies unit leaders of
that impact the achievement of goals event as close to real time as possible.
Risk assessment Analyze risks for impact so the best course Infection prevention and unit leaders perform
of action to address the risk can be taken. root cause analysis of each event to evaluat-
ed risks and opportunities related to event.
Risk response Selection of risk responses including: avoid- Reducing is the risk response for HAIs.
ing, accepting, reducing, or sharing Individual event responses will be determined
with each root cause analysis.
Control activities Policies and procedures support risk HAI team is establishing processes to pre-
responses are carried out effectively. vent HAIs, but also to respond to HAI events
for root cause analysis and response.
Information and communi- Relevant information is identified, captured, HAI team is establishing visual management
cation and communicated so people can fulfil their quality boards for HAI outcomes and “real
responsibilities. time” fallout review and discussion. This infor-
mation will roll up to the HAI steering commit-
tee and organization quality committee.
Monitoring Risk management components are moni- HAI outcomes monitored closely. Process
tored and modifications made as needed. and practice improvements monitored and
adjusted using Plan-Do-Study-Act method as
the data and monitoring warrant.
CAUTI = catheter-associated urinary tract infection, CLABSI = central line associated bloostream infection, C. diff =
Clostridium difficile, CMS = Centers for Medicare & Medicaid Services, HAI = hospital-acquired infection
Situation
There was a catheter-associated urinary tract infection (CAUTI) on 4/1/17. This is our 4th CAUTI in 2017.
Background
Patient is an 84-year-old male with history of BPH, dementia, CVA, and UTI on admission. Admitted through the ED to
hospital on 3/14/17.
3/14/17: Patient fell at home and fractured his hip. Foley catheter placed in ED. Patient admitted to med/surg. No initial
Foley catheter order entered in EHR (order on paper). Patient’s UTI identified as ESBL E. coli on admission and was
placed on isolation and 7-day treatment begun.
3/15/17: Patient to OR then to ICU post op. Order to d/c Foley on POD 2.
3/16/17: Foley was not removed per physician order. Chlorhexidine (CHG) bathing not completed on this day.
3/17/17: Patient cleared for weight bearing as tolerated with PT.
3/19/17: Patient transferred to med/surg.
3/23/17: RN completed the d/c Foley order from 3/15 in chart check, but Foley remained in place. During hospital course,
patient’s mobility was max assist, patient’s health status declined, and there was consideration of comfort care.
4/1/17: Patient febrile with blood and clots in urine. Catheter removed. Blood and urine cultures ordered and collected.
Both resulted positive for Pseudomonas. Patient made comfort care.
Assessment
• Dwell time for Foley catheter placed on admission was 19 days. This is a really long time.
• There was no electronic order for a Foley catheter on admission.
• No electronic insertion order for a Foley catheter defeated all the safeguards imbedded in EHR to prevent a CAUTI.
The major safeguard is a daily justification alert (with reason) for providers to document continued Foley use.
Recommendations
• Ensure every indwelling Foley has an insertion order in the EHR.
• Inquire about continued Foley necessity every day.
• Review line necessity daily. Providers to complete justification alert with proper reason for continuation documented.
• CHG bathing to be completed daily on every ICU patient and every med/surg patient with a Foley or central line.
• Complete and document Foley care daily and prn.
• Ensure Foley secured properly with securement device, tube not kinked, Foley bag in a dependent position: below
level of bladder but not on the ground.
Risk Mitigation each other. The model supports staff workgroup to address the high
The organization strives for typical management components number of HAIs and evaluate HAI
zero HAIs; however, because hos- of an organization (COSO, 2004) outcomes as they relate to process-
pitalized patients typically have (see Table 3). es and practices. Physicians, nurs-
compromised immune systems The 4Ts of hazard manage- es, pharmacists, laboratory techni-
and hospitals treat infectious ment (tolerate, treat, transfer, ter- cians, clinical nurse specialists,
patients, zero HAIs is difficult to minate) are helpful in considering clinical nurse leaders, infection
realize. The organization evaluat- how to address risk. The best prevention (IP) nurses, and envi-
ed its risk appetite related to HAIs. option for HAIs is to manage the ronmental services are representa-
The risk tolerance should mini- risk to prevent the occurrence. tives on the workgroup. The HAI
mally be below the NHSN nation- Decreasing the exposure and workgroup is evaluating the extent
al benchmark for each specific impact of HAIs will manage the evidence-based practice standards
HAI (Hopkin, 2014a). risk. Treat is the appropriate man- are integrated into the organiza-
Risk mitigation tools. The agement strategy because HAIs are tion’s policies. They also assess
Committee of Sponsoring Organi- likely to happen, but they have a work practices related to each HAI
zations of the Treadway Commission mid-range impact to the organiza- to guide improvement activities.
(COSO) Enterprise Risk Manage- tion’s overall risk considerations The HAI workgroup reports events
ment framework is a tool to evalu- (Hopkin, 2014b). Tolerating, trans- and outcomes to the HAI steering
ate risk and develop strategies to ferring, or terminating risk would committee that reports to the orga-
mitigate risk comprehensively. The not apply as options in hazard nization’s quality committee. The
COSO model assists with assessing management strategies for HAIs. accountability to the workgroup’s
various risk components individu- Risk mitigation actions. The actions and the committees pro-
ally, and how they integrate with organization developed a frontline vide resources should the team
CAUTI = catheter-associated urinary tract infection, CLABSI = central line associated bloostream infection, C. diff =
Clostridium difficile, HAI = hospital-acquired infection, PPE = personal protective equipment, PICC = peripherally inserted cen-
tral catheter
encounter barriers with their providing “real time” notification When the IP team learns of a
improvement activities. of and information on HAI cases. HAI from laboratory results, they
Daily management and moni- Information technology and ana- immediately notify the patient’s
toring of HAI events was the first lytical support personnel assist in unit nursing manager and direc-
intervention of the workgroup. delivering HAI-related data to aid tor. The nursing manager, HAI
The team has supported the IP this rapid cycle improvement workgroup representatives, and IP
department in their effort with process. conduct a case review within 1